Leerink Partnrs Expects Stronger Earnings for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Equities researchers at Leerink Partnrs raised their FY2028 earnings per share estimates for shares of Henry Schein in a research report issued on Monday, May 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings of $6.25 per share for the year, up from their prior estimate of $6.00. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm's revenue was down .1% on a year-over-year basis. During the same period in the previous year, the company posted $1.10 EPS.

Several other research firms also recently weighed in on HSIC. Barrington Research dropped their price target on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research note on Tuesday, May 6th. Wells Fargo & Company dropped their price target on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Jefferies Financial Group upped their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. StockNews.com cut Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Finally, UBS Group decreased their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $79.30.

Henry Schein Price Performance

HSIC stock traded up $1.34 during midday trading on Wednesday, hitting $69.98. The company's stock had a trading volume of 624,370 shares, compared to its average volume of 1,632,244. Henry Schein has a 12 month low of $60.56 and a 12 month high of $82.49. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $8.57 billion, a price-to-earnings ratio of 28.79, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The company has a 50 day moving average of $67.59 and a two-hundred day moving average of $71.46.

Insider Activity

In related news, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. This trade represents a 6.05% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.08% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in HSIC. Barclays PLC increased its stake in Henry Schein by 6.9% in the 3rd quarter. Barclays PLC now owns 286,475 shares of the company's stock worth $20,882,000 after buying an additional 18,458 shares during the period. Virtu Financial LLC purchased a new position in Henry Schein during the 3rd quarter valued at about $239,000. Wilmington Savings Fund Society FSB purchased a new position in Henry Schein during the 3rd quarter valued at about $109,000. Tidal Investments LLC increased its position in Henry Schein by 54.9% during the 3rd quarter. Tidal Investments LLC now owns 13,942 shares of the company's stock valued at $1,016,000 after purchasing an additional 4,939 shares during the period. Finally, Franklin Resources Inc. increased its position in Henry Schein by 14.0% during the 3rd quarter. Franklin Resources Inc. now owns 37,637 shares of the company's stock valued at $2,673,000 after purchasing an additional 4,621 shares during the period. Hedge funds and other institutional investors own 96.62% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.